Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121835182 | 12183518 | 2 | F | 201603 | 20160824 | 20160316 | 20160826 | EXP | US-HLSUS-2016-US-000128 | HLS THERAPEUTICS | 59.00 | YR | A | M | Y | 67.00000 | KG | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121835182 | 12183518 | 1 | PS | CLOZARIL | CLOZAPINE | 1 | Oral | 400 MG QHS | 0 | 400 | MG | TABLET | QD | ||||||
| 121835182 | 12183518 | 2 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 121835182 | 12183518 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG QD | 0 | 5 | MG | QD | |||||||
| 121835182 | 12183518 | 4 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | 0 | ||||||||||||
| 121835182 | 12183518 | 5 | C | BUDESONIDE. | BUDESONIDE | 1 | 0 | ||||||||||||
| 121835182 | 12183518 | 6 | C | GLYCOPYRROLATE. | GLYCOPYRROLATE | 1 | Oral | 0 | 1 | MG | |||||||||
| 121835182 | 12183518 | 7 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 150 MG QHS | 0 | 150 | MG | QD | |||||||
| 121835182 | 12183518 | 8 | C | VIMPAT | LACOSAMIDE | 1 | 0 | 50 | MG | ||||||||||
| 121835182 | 12183518 | 9 | C | ABILIFY | ARIPIPRAZOLE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121835182 | 12183518 | 1 | Schizophrenia |
| 121835182 | 12183518 | 2 | Chronic obstructive pulmonary disease |
| 121835182 | 12183518 | 3 | Hypertension |
| 121835182 | 12183518 | 4 | Chronic obstructive pulmonary disease |
| 121835182 | 12183518 | 6 | Drooling |
| 121835182 | 12183518 | 7 | Sleep disorder |
| 121835182 | 12183518 | 8 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121835182 | 12183518 | DE |
| 121835182 | 12183518 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121835182 | 12183518 | Lung neoplasm malignant | |
| 121835182 | 12183518 | Myocardial infarction | |
| 121835182 | 12183518 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121835182 | 12183518 | 1 | 1999 | 201603 | 0 | |
| 121835182 | 12183518 | 9 | 201603 | 0 |